Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Ophthalmology Research

16-EYE-2652-Sears-CQD-Hero

Stimulating Angiogenesis to Prevent Retinopathy of Prematurity

Researchers prove HIF proteins inhibit oxygen-induced retinopathy

16-EYE-2648-OTC-CQD-650p

Continuing to Push New Frontiers in OCT

Bringing OCT into the OR and more

16-EYE-2701-Ngenuity-CQD-650p

New 3-D Technology for Eye Surgery Offers Multiple Advantages

Better for surgeon, surgical team, patients

16-eye-2656-protocol-t-cqd-650×450

Best Practice Identified for Treating Wet AMD with Persistent Leakage

Aflibercept dosing schedule works best

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

16-EYE-2650-iOCT-CQD-Feat

An Inflection Point in Surgical Visualization

Advances in heads-up display and intraoperative OCT

16-eye-2653-traboulsi-cqd-650×450

Gene Therapy for Inherited Retinal Diseases

Treatments for retinal dystrophies are in sight

16-eye-2656-protocol-t-cqd-650×450

Protocol T Leads to Revised Approach to DME Treatment

How results changed our practice

16-eye-2651-regeneration-cqd-650×450

Regenerating the Retina

Characterizing the retina’s injury response

16-eye-1562-octa-cqd-650×450

Visualizing Paracentral Acute Middle Maculopathy with OCT Angiography

OCT Angiography critical in recent case

16-EYE-802-Neurotech-CQD-650×450

Cleveland Clinic Studies New Drug Therapy Delivery Methods With Major Impact on Treatment of Eye Diseases

Implants can reverse disease state, replace injections

BackPage 5 of 7Next

Advertisement

Ad